Trial
NCT06859294
A Study of LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid Arthritis
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Rheumatoid Arthritis
Intervention
LY3541860
Why stopped
The interim analysis data failed to demonstrate the intended treatment effect.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-17